Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

31,147 trials

NCT07684235
Recruiting
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
Phase 3 · Australia, Canada, Japan, Puerto Rico, United States · 91 sites
Registry update: 5 Oct 2026
NCT07635329
Recruiting
Home-based Vision Rehabilitation Guided by Brain Imaging
Not applicable · United States · 1 site
Registry update: 14 Sept 2026
NCT06802172
Recruiting
Effect of Meal Timing During Cancer Treatment in Patients in Alaska: A Randomized Clinical Trial
Not applicable · United States · 1 site
Registry update: 29 Jul 2026
NCT07383506
Recruiting
A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors
Phase 1 · United States · 12 sites
Registry update: 22 Oct 2026
NCT07684157
Recruiting
A Phase IIa Study of JAB-8263 in Patients With Active Rheumatoid Arthritis
Phase 2 · China · 1 site
Registry update: 28 Sept 2026
2023-510560-12-00
Recruiting
Phase II Open-Label, Single Arm, Multicenter Study of Ciltacabtagene Autoleucel in High-Risk Smoldering Multiple Myeloma
Phase 2 · Spain · 9 sites
Registry update: 23 Jul 2026
NCT06990061
Recruiting
Radiotherapy for BCG-unresponsive Non-muscle-invasive Carcinoma in Situ (CIS) Bladder Cancer: an Open-label, Single-arm, Multicentre, Phase 2 Study
Not applicable · Belgium · 3 sites
Registry update: 11 Sept 2026
NCT07746102
Recruiting
Assessment of the Impact of Repeated Ischemic Preconditioning Episodes on Hemodynamic and Metabolic Parameters in Patients at Various Stages of Chronic Kidney Disease
Not applicable · Poland · 1 site
Registry update: 4 Aug 2026
NCT07652281
Recruiting
A Clinical Study of SHR-5421 in Patients With Multiple Myeloma
Phase 1 · China · 1 site
Registry update: 30 Jul 2026
NCT07432594
Recruiting
Neoadjuvant Aitua (PD-1/CTLA-4 Bispecific) Plus Nab-Paclitaxel and Carboplatin for Advanced High-Grade Serous Ovarian Cancer
Phase 2 · China · 1 site
Registry update: 4 Nov 2026
NCT07531719
Recruiting
A Study of Risdiplam in Participants With Type I and Type II Spinal Muscle Atrophy (SMA)
Not applicable · Egypt · 2 sites
Registry update: 2 Oct 2026
NCT07701993
Recruiting
A Pivotal Clinical Study to Investigate the Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)
Phase 3 · Japan, United States · 27 sites
Registry update: 5 Nov 2026
NCT07105397
Recruiting
Evaluating Conversational Artificial Intelligence for Depression Management
Not applicable · United States · 1 site
Registry update: 9 Sept 2026
NCT06872346
Recruiting
Personalized Risk-based Follow-up of Cervical Cancer Screening in Practice, RCT
Not applicable · United States · 1 site
Registry update: 7 Aug 2026
NCT07844148
Recruiting
A Study to Compare GNR-139 and Eylea® in Patients With nAMD
Phase 3 · Russia · 14 sites
Registry update: 30 Sept 2026
2025-523660-21-00
Recruiting
A Non-Investigational Product, Multi-Center Cohort Study to Describe Long-Term Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec
Phase 3 · Germany, Spain, France, Greece, Italy, Sweden · 9 sites
Registry update: 23 Oct 2026
NCT07599579
Recruiting
Mobile Health Program for Post-Preeclampsia Hypertension
Not applicable · United States · 1 site
Registry update: 29 Jul 2026
NCT07135271
Recruiting
BeSpoke Decision Support for Patients With Newly Diagnosed Localised Prostate Cancer
Not applicable · United Kingdom · 1 site
Registry update: 29 Jul 2026
NCT07560397
Recruiting
Feasibility Study on the Implementation of a Supervised, Home-based Adapted Physical Activity Program for Patients With Head and Neck Cancer
Not applicable · France · 1 site
Registry update: 23 Jul 2026
NCT07713914
Recruiting
Randomized Study of Triple Therapy vs Sildenafil Dose Optimization in Pulmonary Arterial Hypertension
Phase 4 · Brazil · 1 site
Registry update: 30 Jul 2026

Ordered by registry start date. Freshness and sponsorship never change the order.